NEWBORN METABOLIC SCREENING PROGRAM
The goal of newborn blood spot screening is to identify newborns at risk for life-threatening and debilitating conditions that would otherwise not be detected until damage has occurred, and for which intervention and/or treatment can improve the baby's outcome. |
South Dakota Codified Law 34-24-17 through 34-24-25 and Administrative Rules of South Dakota 44:19 require all newborns to be screened for certain metabolic, inherited and genetic disorders.
Newborn Screening is a system coordinated by the South Dakota Department of Health in collaboration with hospitals, laboratories, health care professionals and families. The contract newborn screening laboratory for South Dakota is the State Hygienic Laboratory at the University of Iowa (SHL).
Severe Combined Immunodeficiency (SCID) Screening began in South Dakota September 1, 2015
Public Health Genomics Knowledge Base (v1.2)
Last Posted: Nov-10-2016 11AM
Severe Combined Immunodeficiency expanded expanded
Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
de Pagter Anne P J et al. European journal of pediatrics 2015 Sep 174(9) 1183-8
de Pagter Anne P J et al. European journal of pediatrics 2015 Sep 174(9) 1183-8
Newborn screening for severe combined immune deficiency (SCID) saves lives and money: a cost-effective public health policy
S Grosse, Blog post, March 15, 2016
S Grosse, Blog post, March 15, 2016
Newborn screening for severe combined immune deficiency (technical and political aspects).
Kobrynski Lisa et al. Current opinion in allergy and clinical immunology 2015 Dec (6) 539-46
Kobrynski Lisa et al. Current opinion in allergy and clinical immunology 2015 Dec (6) 539-46
More information on this topic
Last Updated: Nov 09, 2016
- Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
de Pagter Anne P J et al. European journal of pediatrics 2015 Sep 174(9) 1183-8 - Newborn screening for severe combined immune deficiency (SCID) saves lives and money: a cost-effective public health policy
S Grosse, Blog post, March 15, 2016 - Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
Cavazzana Marina et al. Human gene therapy 2016 Feb (2) 108-16 - Newborn screening for severe combined immune deficiency (technical and political aspects).
Kobrynski Lisa et al. Current opinion in allergy and clinical immunology 2015 Dec (6) 539-46 - Newborn Metabolic Screening Program
Disease: NA; Type: Program; State: South Dakota - A New IL-2RG Gene Mutation in an X-linked SCID Identified through TREC/KREC Screening: a Case Report.
Nourizadeh Maryam, et al. Iranian journal of allergy, asthma, and immunology 2015 8 (4) 457-61 - Severe combined immunodeficiencies and related disorders
A Fischer et al. Nature Reviews Disease Primers, November 2015 - Severe Combined Immunodeficiency Disorders.
Chinn Ivan K et al. Immunology and allergy clinics of North America 2015 Nov (4) 671-94 - Severe combined immunodeficiency-an update.
Cirillo Emilia et al. Annals of the New York Academy of Sciences 2015 Jul - [New recommendations for the Dutch neonatal screening programmeA report from the Health Council of the Netherlands].
Published on 2015 by Health Council of the Netherlands - Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.
Bayer D K et al. Clin. Exp. Immunol. 2014 Dec 178(3) 459-69 - Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
Adams Stuart P, et al. Clinical immunology (Orlando, Fla.) 2015 8 (2) 174-179 - Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
Okada Satoshi, Markle Janet G, Deenick Elissa K, Mele Federico, Averbuch Dina, Lagos Macarena, Alzahrani Mohammed, Al-Muhsen Saleh, Halwani Rabih, Ma Cindy S, Wong Natalie, Soudais Claire, Henderson Lauren A, Marzouqa Hiyam, Shamma Jamal, Gonzalez Marcela, Martinez-Barricarte Rubén, Okada Chizuru, Avery Danielle T, Latorre Daniela, Deswarte Caroline, Jabot-Hanin Fabienne, Torrado Egidio, Fountain Jeffrey, Belkadi Aziz, Itan Yuval, Boisson Bertrand, Migaud Mélanie, Arlehamn Cecilia S Lindestam, Sette Alessandro, Breton Sylvain, McCluskey James, Rossjohn Jamie, de Villartay Jean-Pierre, Moshous Despina, Hambleton Sophie, Latour Sylvain, Arkwright Peter D, Picard Capucine, Lantz Olivier, Engelhard Dan, Kobayashi Masao, Abel Laurent, Cooper Andrea M, Notarangelo Luigi D, Boisson-Dupuis Stéphanie, Puel Anne, Sallusto Federica, Bustamante Jacinta, Tangye Stuart G, Casanova Jean-Laurent.Science 2015 Jul 9. - Actionable diagnosis of neuroleptospirosis by next-generation sequencing.
Wilson Michael R et al. N. Engl. J. Med. 2014 Jun 19. 370(25) 2408-17 - Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
Taylor Jennifer L et al. Clin. Chem. 2015 Feb 61(2) 412-9
- Human (10)
- Pathogen (0)
- Human (14)
- Pathogen (0)
- Guidelines (1)
- Tier Table (0)
- Synthesis (4)
- Huamn (3)
- Pathogen (0)
No hay comentarios:
Publicar un comentario